Approximately 1–2% of NSCLC patients harbor RET fusions (Cancer Genome Atlas Research Network 2014), and they tend to be young, non-smokers, and adenocarcinomas (Wang et al. 2012). This evidence concerns the gene RET and non-small cell lung carcinoma.